Rosenblum Reveals New Fibroblast–Immune Axis in Skin Inflammation

At the 2025 Inflammatory Skin Disease Summit, Michael Rosenblum, MD, PhD, professor of dermatology at UCSF, presented an in-depth account of more than a decade of work examining regulatory T cells (Tregs) and their interactions with stromal…

Continue Reading